Increased expression of cyclin-dependent kinase inhibitor 2 (CDKN2A) gene product p16(INK4A) in ovarian cancer is associated with progression and unfavourable prognosis

Dong, Y, Walsh, MD, McGuckin, MA, Gabrielli, BG, Cummings, MC, Wright, RC, Hurst, T, Khoo, SK and Parsons, PG (1997) Increased expression of cyclin-dependent kinase inhibitor 2 (CDKN2A) gene product p16(INK4A) in ovarian cancer is associated with progression and unfavourable prognosis. International Journal of Cancer, 74 1: 57-63. doi:10.1002/(SICI)1097-0215(19970220)74:1<57::AID-IJC10>3.0.CO;2-F


Author Dong, Y
Walsh, MD
McGuckin, MA
Gabrielli, BG
Cummings, MC
Wright, RC
Hurst, T
Khoo, SK
Parsons, PG
Title Increased expression of cyclin-dependent kinase inhibitor 2 (CDKN2A) gene product p16(INK4A) in ovarian cancer is associated with progression and unfavourable prognosis
Journal name International Journal of Cancer   Check publisher's open access policy
ISSN 0020-7136
Publication date 1997-02-01
Sub-type Article (original research)
DOI 10.1002/(SICI)1097-0215(19970220)74:1<57::AID-IJC10>3.0.CO;2-F
Volume 74
Issue 1
Start page 57
End page 63
Total pages 7
Language eng
Keyword Cell-Lines
Mutations
P16
Chromosome-9
Deletions
Melanoma
Tumors
Q-Index Code C1
Q-Index Status Provisional Code
Institutional Status Unknown

Document type: Journal Article
Sub-type: Article (original research)
Collection: ResearcherID Downloads - Archived
 
Versions
Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 74 times in Thomson Reuters Web of Science Article | Citations
Scopus Citation Count Cited 80 times in Scopus Article | Citations
Google Scholar Search Google Scholar
Created: Sat, 19 Apr 2014, 04:24:33 EST by System User